A Single Center Retrospective Cohort Study of Auto-intoxicated Patients Admitted to the ICU

September 19, 2023 updated by: Stessel Björn, Jessa Hospital

A Single Center Retrospective Cohort Study of Auto-intoxicated Patients Admitted to the ICU: Descriptive Analysis

Intentional poisoning is a relevant public health issue responsible for a considerable number of cases of morbidity and mortality worldwide. There are no concrete numbers/investigations of these patients admitted to the ICU at our hospital, with limited insight on their characteristics and outcome.

It is expected that this population of patients is an important burden for the ICU. It can be important to shed a light on prevalence and ratio of intoxicated patients admitted to the ICU in our center.

Furthermore, during the covid-pandemic, we could expect an increase in self-poisoning prevalence due to social restrictions, more limited access to (mental) health care, etc…

Study Overview

Status

Completed

Conditions

Detailed Description

Aim The aims of this study are to quantify the ratio of intensive care admissions attributable to self-poisoning in our hospital, to examine characteristics and outcome of these patients, yearly trends and impact of the covid-pandemic on these variables.

Design A single center retrospective cohort study analysis of patients with self-poisoning admitted to ICU of the Jessa Hospital Hasselt Belgium over a period of 6 years (2017-2022).

Sample size

All patients diagnosed with self-poisoning admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study. This were 377 patients.

Study population

Inclusion and exclusion criteria:

All patients (>14 years of age) diagnosed with self-poisoning and admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study.

Patient admitted for tentamen suicide but not due to intoxication were excluded as well as patients with no medical records in the Jessa hospital.

Primary Outcome The prevalence of auto-intoxicated patients admitted to the ICU together with the mortality rate on the ICU.

Secondary Outcome measurements

Secondary outcome measurement are the ICU and hospital length of stay, ratio of auto-intoxicated patients to all patients admitted at ICU, types of drugs ingested, number of drugs involved, cause of admission, yearly trends and impact of covid-pandemic.

Statistical analysis Data will be presented as mean values +/-SD, numbers(n), and percentages(%) or median (25%, 75% percentile) in case of non-parametric data. Categorical variables are presented as frequencies (%) and groups were compared using Chi-square or Fisher's exact test.

Differences between patients change will be analyzed using the Student t test for continuous outcomes or, in case of non-parametric data, the Mann-Whitney U test. Univariate and multivariate logistic regression models will be used in order to predict mortality. P values <0.05 will be considered statistically significant.

Additional data collection:

Additional collected parameters are listed below and are collected as a standard-of-care in our hospital:

  • Demographics: i.e age, gender, BMI
  • DNR-code
  • Admission route
  • Patient state and symptoms: i.e vital signs, GCS, …
  • Comorbidities: i.e smoking, obesity, hypertension, diabetes, cardiovascular disease, respiratory disease, malignancies, renal failure, liver failure, neurological conditions, mental state and disease
  • Technical investigation results: i.e Laboratory results, ECG, radiological findings, etc…
  • Complications: i.e shock, heart failure, sepsis, stroke, etc…
  • Ventilation: method, PEEP, FiO2, P/F ratio,…
  • Management: i.e antidote, supportive, mechanical ventilation, dialysis, observation,

Study Type

Observational

Enrollment (Actual)

377

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hasselt, Belgium, 3500
        • Jessa Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All patients (>14 years of age) diagnosed with self-poisoning and admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study.

Description

Inclusion Criteria:

All patients (>14 years of age) diagnosed with self-poisoning and admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study.

Exclusion Criteria:

Patient admitted for tentamen suicide but not due to intoxication were excluded as well as patients with no medical records in the Jessa hospital.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of mortality
Time Frame: patient admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
The prevalence of auto-intoxicated patients admitted to the ICU together with the mortality rate on the ICU.
patient admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ICU length of stay
Time Frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
Length of stay in the ICU
patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
hospital length of stay
Time Frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
Length of stay in the hospital
patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
Relative number of auto-intoxicated patients at ICU
Time Frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
ratio of auto-intoxicated patients to all patients admitted at ICU,
patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
Type
Time Frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
type of drugs ingested by patients admitted to ICU
patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
Impact of COVID-19 pandemic
Time Frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
the impact of the COVID-19 pandemic on the number of auto-intoxicated patients admitted to ICU
patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
number of drugs or medication
Time Frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
number of drugs or medication ingested by patients admitted to ICU
patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
Cause
Time Frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022
cause of admission to ICU: emotional, relational, somatic, psychological, financial, workrelated, recreative, other or unknown
patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2023

Primary Completion (Actual)

September 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

June 28, 2023

First Submitted That Met QC Criteria

June 28, 2023

First Posted (Actual)

July 6, 2023

Study Record Updates

Last Update Posted (Actual)

September 21, 2023

Last Update Submitted That Met QC Criteria

September 19, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • f/2023/041

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intoxication, Depth

3
Subscribe